기도 관리 디바이스 시장 보고서 : 제품 유형별, 환자 유형별, 용도별, 최종 용도별, 지역별(2026-2034년)

The global airway management devices market size reached USD 2.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.9 Billion by 2034, exhibiting a growth rate (CAGR) of 5.34% during 2026-2034. The widespread consumer understanding of multiple product benefits is stimulating the market.

AIRWAY MANAGEMENT DEVICES MARKET ANALYSIS:

• Major Market Drivers: The increasing prevalence of respiratory diseases, along with the rising need for maintenance of proper ventilation and patient safety during operative procedures, is augmenting the market.
• Key Market Trends: The growing number of surgeries involving higher utilization of anesthesia is acting as a significant growth-inducing factor.
• Competitive Landscape: Some of the major market companies include Ambu A/S, Armstrong Medical Ltd., Becton Dickinson and Company, Flexicare (Group) Limited, Intersurgical Ltd., Medline Industries Inc, Medtronic plc, Mercury Enterprises Inc., Smiths Group plc, Teleflex Incorporated, VBM Medizintechnik GmbH, and Verathon Inc. (Roper Technologies Inc.), among many others.
• Geographical Trends: Asia Pacific leads the market, owing to the increasing healthcare expenditure, rising surgical procedures, and a growing elderly population.
• Challenges and Opportunities: The risk of device-related complications is hampering the market. However, advancements in design, improved training for healthcare personnel, and the introduction of breakthrough technologies that promote safety and efficacy will continue to catalyze the market over the forecast period.

AIRWAY MANAGEMENT DEVICES MARKET TRENDS:

Increasing Focus on Noninvasive Devices

Noninvasive airway solutions, such as ventilation masks, are becoming more popular in critical care because they maintain airways without intrusive procedures, lowering discomfort and recovery time. In August 2024, a study conducted by researchers at the University of Wisconsin School of Medicine and Public Health showed that the noninvasive ventilation method, which supports breathing by using a tight-fitting respiratory mask connected to BPAP, or bilevel positive airway pressure, reduced the risks associated with the intubation procedure. This is increasing the airway management devices market growth.

Elevating Usage of Single-Use Devices

The emphasis on infection prevention has resulted in increased demand for single-use airway management devices. These disposable devices minimize the possibility of cross-contamination and hospital-acquired illnesses. In June 2024, Applied Medical Technology, Inc. (AMT), a global leader in manufacturing medical devices, announced the debut of IntelAir, a nasal airway support system. The single-use device is intended to ensure airway securement, avoid cannula migration, and maintain a clear airway. This represents the airway management devices market outlook.

Widespread Popularity of Pediatric Airway Management

Pediatric airway devices are in frequent use due to children's particular anatomical requirements. Companies are creating smaller and more flexible technologies for safe use in neonatal and pediatric care, with a focus on precision and safety. In September 2024, Baxter International Inc., a leading global medtech company, unveiled its next-generation airway clearance system, the vest advanced pulmonary experience (APX) system, at the North American Cystic Fibrosis Conference. This system supports daily therapy for adults and children with certain chronic lung conditions and retained secretions.

GLOBAL AIRWAY MANAGEMENT DEVICES INDUSTRY SEGMENTATION:

Breakup by Product:

• Supraglottic Devices
  • Oropharyngeal Devices
  • Naspharyngeal Devices
  • Laryngeal Airway Devices
  • Others
• Infraglottic Devices
  • Endotracheal Tubes
  • Tracheostomy Tubes
  • Others
• Resuscitators
• Laryngoscopes

Currently, infraglottic devices hold the largest airway management devices market share

Infraglottic devices, such as endotracheal tubes and tracheostomy tubes, are important in airway management, especially in emergency and surgical circumstances. These devices are intended to offer consistent breathing support and are necessary for individuals who require long-term airway medical attention. This is elevating the airway management devices market statistics.

Breakup by Patient Type:

• Adult
• Pediatric Patient/Neonates

Among these, adult currently holds the largest share of the airway management devices industry

Adult patients drive a high demand for equipment, such as laryngeal masks, endotracheal tubes, and resuscitators, due to higher rates of chronic respiratory disorders and procedures. Adults require effective airway control in emergency care, anesthesia, and intensive care units.

Breakup by Application:

• Anesthesia
• Emergency Medicine

Currently, anesthesia holds the largest share of the market

Anesthesia application improves the popularity of devices, such as laryngeal masks and endotracheal tubes, which ensure secure airways during procedures. Proper airway control is critical for patient safety in anesthesia, making these devices necessary in operating rooms.

Breakup by End Use:

• Hospitals
• Homecare

Among these, hospitals currently hold the largest airway management devices market demand

Hospitals represent the largest category due to the high volume of surgeries, emergency care requirements, and critical care situations. Endotracheal tubes and laryngeal masks are critical in hospital settings, fueling demand for dependable airway control options. This is boosting the airway management devices market revenue.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Asia-Pacific currently dominates the market

The airway management devices market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia-Pacific accounted for the largest market share.

Asia-Pacific exhibits a clear dominance in the market driven by the region's expanding healthcare investments, more surgeries, and improved medical infrastructure. Countries, such as China, India, and Japan make significant contributions, owing to an aging population and respiratory diseases. The region's rising healthcare access and demand for innovative medical equipment are driving market growth.

COMPETITIVE LANDSCAPE:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What is the expected growth rate of the global airway management devices market during 2026-2034?

2. What are the key factors driving the global airway management devices market?

3. What has been the impact of COVID-19 on the global airway management devices market?

4. What is the breakup of the global airway management devices market based on the product?

5. What is the breakup of the global airway management devices market based on the patient type?

6. What is the breakup of the global airway management devices market based on the application?

7. What is the breakup of the global airway management devices market based on the end use?

8. What are the key regions in the global airway management devices market?

9. Who are the key players/companies in the global airway management devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Airway Management Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Supraglottic Devices
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Oropharyngeal Devices
    • 6.1.2.2 Naspharyngeal Devices
    • 6.1.2.3 Laryngeal Airway Devices
    • 6.1.2.4 Others
  • 6.1.3 Market Forecast
• 6.2 Infraglottic Devices
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Endotracheal Tubes
    • 6.2.2.2 Tracheostomy Tubes
    • 6.2.2.3 Others
  • 6.2.3 Market Forecast
• 6.3 Resuscitators
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Laryngoscopes
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Others
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Patient Type

• 7.1 Adult
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Pediatric Patient/Neonates
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Application

• 8.1 Anesthesia
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Emergency Medicine
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by End Use

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Homecare
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Ambu A/S
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Armstrong Medical Ltd.
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 Becton Dickinson and Company
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 Flexicare (Group) Limited
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 Intersurgical Ltd.
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 SWOT Analysis
  • 15.3.6 Medline Industries Inc
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 SWOT Analysis
  • 15.3.7 Medtronic plc
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 Mercury Enterprises Inc.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 Smiths Group plc
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Teleflex Incorporated
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
    • 15.3.10.4 SWOT Analysis
  • 15.3.11 VBM Medizintechnik GmbH
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
  • 15.3.12 Verathon Inc. (Roper Technologies Inc.)
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio
    • 15.3.12.3 SWOT Analysis